drugset / Trial / NCT04882956
BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration
RandomizedParallel-groupSingle-blindTreatment
Summary
Age-Related macular neovascularization degeneration occur is a vision threatening condition. The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the management.
Timeline
- Start
- 2020-08-05
- Primary completion
- 2021-12
- Completion
- 2022-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aflibercept | Protein / enzyme biologic | — | Intravitreal |
| Comparator | Brolucizumab | Other / unclassified | — | Intravitreal |